References
Pearce EN, Farwell AP, Braverman LE. Thyroiditis. N Engl J Med 2003, 348: 2646–55.
Volpe R, Ehrlich R, Steiner G, Row VV. Graves’ disease in pregnancy years after hypothyroidism with recurrent passive-transfer neonatal Graves’ disease in offspring. Therapeutic considerations. Am J Med 1984, 77: 572–8
Wakakuri N, Kubo T, Kitagawa M. Hyperthyroidism after primary hypothyroidism. Follow-up with serial thyroid biopsies. Arch Intern Med 1985, 145: 1527–8.
Cho BY, Shong YK, Lee HK, Koh CS, Min HK. Graves’ hyperthyroidism following primary hypothyroidism: sequential changes in various activities of thyrotropin rceptor antibodies. Acta Endocrinol (Copenh) 1989, 120: 447–50
Kraiem Z, Baron E, Kahana L, Sadeh O, Sheinfeld M. Changes in stimulating and blocking TSH receptor antibodies in a patient undergoing three cycles of transition from hypo to hyper-thyroidism and back to hypothyroidism. Clin Endocrinol (Oxf) 1992, 36: 214–6.
Kung AW, Lau KS, Kohn LD. Epitope mapping of TSH receptor-blocking antibodies in Graves’ disease that appear during pregnancy. J Clin Endocrinol Metab 2001, 86: 3647–53.
Amino N, Izumi Y, Hidaka Y, et al. No increase of blocking type anti-thyrotropin receptor antibodies during pregnancy in patients with Graves’ disease. J Clin Endocrinol Metab 2003, 88: 5871–4.
Ueta Y, Fukui H, Murakami H, et al. Development of primary hypothyroidism with the appearance of blocking-type antibody to thyrotropin receptor in Graves’ disease in late pregnancy. Thyroid 1999, 9: 179–82.
Mandel SJ, Larsen PR, Seely EW, Brent GA. Increased need for thyroxine during pregnancy in women with primary hypothyroidism. N Engl J Med 1990, 323: 91–6.
Mazziotti G, Sorvillo F, Iorio S, et al. Grey-scale analysis allows a quantitative evaluation of thyroid echogenicity in the patients with Hashimoto’s thyroiditis. Clin Endocrinol (Oxf) 2003, 59: 223–9.
Haddow JE, Palomaki GE, Allan WC, et al. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med 1999, 341: 549–55.
Alexander EK, Marqusee E, Lawrence J, Jarolim P, Fischer GA, Larsen PR. Timing and magnitude of increases in levothyroxine requirements during pregnancy in women with hypothyroidism. N Engl J Med 2004, 351: 241–9.
Rotondi M, Mazziotti G, Sorvillo F, et al. Effects of increased thyroxine dosage pre-conception on thyroid function during early pregnancy. Eur J Endocrinol 2004, 151: 695–700.
Costagliola S, Morgenthaler NG, Hoermann R, et al. Second generation assay for thyrotropin receptor antibodies has superior diagnostic sensitivity for Graves’ disease. J Clin Endocrinol Metab 1999, 84: 90–7.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gola, M., Doga, M., Mazziotti, G. et al. Development of Graves’ hyperthyroidism during the early phase of pregnancy in a patient with pre-existing and long-standing Hashimoto’s hypothyroidism. J Endocrinol Invest 29, 288–290 (2006). https://doi.org/10.1007/BF03345556
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03345556